Install
- 6,371articles · 30d
- 7+ hour agolatest article
- Aug 15, 2026earliest in window
- 91%with images
- 271avg words
- Economy, Business & Finance 2,999
- Finance & Business 2,325
- News 1,948
- Business & Industrial 774
- Politics 622
- Finance 561
- Science & Technology 439
- Arts, Culture, Entertainment & Media 429
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
ACGME Announces Winner of National Nutrition Essay Contest
3+ day, 22+ hour ago (224+ words) Bonnie Nguyen, DO, a family medicine resident at Kaiser Permanente Santa Rosa, is the winner of the national ACGME's nutrition essay contest A total of 230 essays were submitted by residents and fellows representing 39 specialties and a range of institutions. Entries…...
Sweden immigration restrictions spark healthcare concerns
5+ day, 30+ min ago (714+ words) TROLLHATTAN, Sweden — A dramatic tightening of Sweden's migration policy has sparked concern in a healthcare sector that is ever more dependent on immigrants, professionals warned ahead of a general election on Sunday. "I'm the only one born in Sweden here…...
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
5+ day, 1+ hour ago (190+ words) Company to engage with the global ophthalmology and investment community as it advances urcosimod through its global Phase 3 pivotal trial for neuropathic corneal pain LONDON and NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company…...
GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
5+ day, 7+ hour ago (200+ words) The Commercial Opportunity for GENFIT Beyond the United States - In Europe and Asia, GENFIT expects its IVD2 strategy to play a key role in the future commercialization of its NISTM Technology. Supported by the anticipated expansion of the MASH therapeutic market…...
Inventiva to Present Multiple Abstracts at Paris MASH 2026
5+ day, 16+ hour ago (847+ words) The Manila Times - Phase 1 and Phase 2 clinical data showed lanifibranor improves metabolic profile and cardiovascular risk factors in patients with MASH with or without type 2 diabetes - Preclinical data further characterize lanifibranor’s balanced pan-PPAR pharmacology and support a differentiated fluid and…...
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
5+ day, 18+ hour ago (120+ words) The Manila Times OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today…...
Radicle Science Expands Leadership Across Science, Data, and Health Economics for Precision Wellness
5+ day, 16+ hour ago (261+ words) Three new scientific leaders and the appointment of former White House Chief Healthcare Economist Jonathan Ketcham, PhD, to the advisory board deepen Radicle’s ability to turn rigorous evidence into precision insights, better health outcomes and measurable economic value SAN DIEGO,…...
Fisher Center Foundation Launches New Initiative to Target Memory Loss in Alzheimer’s Disease
5+ day, 20+ hour ago (202+ words) "Memory loss is among the most painful and deeply personal consequences of Alzheimer’s disease,” said Lucretia Holden, Executive Director of the Fisher Center Foundation. "The Fisher Memory Initiative reflects our commitment to supporting bold research that approaches this crucial challenge…...
Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1)
6+ day, 7+ hour ago (465+ words) The Manila Times Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1) Ad hoc announcement pursuant to Art. 53 LR - HARBOR did not meet its primary endpoint of vHOT in DM1, a progressive…...
From Smart Massage to Proactive Wellness: SKG Expands Its Wearable Health Portfolio at IFA 2026
6+ day, 4+ hour ago (283+ words) BERLIN, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SKG Health is showcasing an expanded portfolio of wearable health products at IFA 2026, highlighting its move from portable massage into recovery, training support and proactive health monitoring. International media and visitors from Germany and across Europe…...